Immune-Based Endotyping Reveals Four Distinct Subgroups in Type 2 Diabetes
Audio narration · Coming soon
This study identifies four subgroups of Type 2 Diabetes characterized by distinct immune profiles and varying risks. The findings highlight the potential for targeted therapeutic interventions based on inflammatory markers.
Why this matters
PRISM scored this story 60/100 for interest.
Originally published by gnews